Aardvark Therapeutics Statistics
Total Valuation
AARD has a market cap or net worth of $326.82 million. The enterprise value is $201.01 million.
Important Dates
The next estimated earnings date is Saturday, February 14, 2026, after market close.
| Earnings Date | Feb 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AARD has 21.77 million shares outstanding. The number of shares has increased by 282.40% in one year.
| Current Share Class | 21.77M |
| Shares Outstanding | 21.77M |
| Shares Change (YoY) | +282.40% |
| Shares Change (QoQ) | +0.11% |
| Owned by Insiders (%) | 14.74% |
| Owned by Institutions (%) | 19.39% |
| Float | 11.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.67 |
| P/TBV Ratio | 2.67 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.03, with a Debt / Equity ratio of 0.00.
| Current Ratio | 12.03 |
| Quick Ratio | 11.77 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -48.06% and return on invested capital (ROIC) is -32.70%.
| Return on Equity (ROE) | -48.06% |
| Return on Assets (ROA) | -30.81% |
| Return on Invested Capital (ROIC) | -32.70% |
| Return on Capital Employed (ROCE) | -43.65% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.22M |
| Employee Count | 22 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 12.88 |
| 200-Day Moving Average | 11.68 |
| Relative Strength Index (RSI) | 57.87 |
| Average Volume (20 Days) | 169,524 |
Short Selling Information
The latest short interest is 1.67 million, so 7.66% of the outstanding shares have been sold short.
| Short Interest | 1.67M |
| Short Previous Month | 1.51M |
| Short % of Shares Out | 7.66% |
| Short % of Float | 15.03% |
| Short Ratio (days to cover) | 6.32 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -53.47M |
| Pretax Income | -48.77M |
| Net Income | -48.77M |
| EBITDA | -53.44M |
| EBIT | -53.47M |
| Earnings Per Share (EPS) | -$3.21 |
Full Income StatementBalance Sheet
The company has $126.35 million in cash and $545,000 in debt, with a net cash position of $125.81 million or $5.78 per share.
| Cash & Cash Equivalents | 126.35M |
| Total Debt | 545,000 |
| Net Cash | 125.81M |
| Net Cash Per Share | $5.78 |
| Equity (Book Value) | 122.38M |
| Book Value Per Share | 5.63 |
| Working Capital | 118.47M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$45.09 million and capital expenditures -$101,000, giving a free cash flow of -$45.19 million.
| Operating Cash Flow | -45.09M |
| Capital Expenditures | -101,000 |
| Free Cash Flow | -45.19M |
| FCF Per Share | -$2.08 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AARD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -282.40% |
| Shareholder Yield | n/a |
| Earnings Yield | -14.92% |
| FCF Yield | -13.83% |
Analyst Forecast
The average price target for AARD is $31.11, which is 107.26% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $31.11 |
| Price Target Difference | 107.26% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |
